Javier Terriente

Javier Terriente

Safety and efficacy  assessment

PhD, CSO and co-founder of ZeClinics, a biotech company specialized in using zebrafish for assessing the safety and efficacy of novel molecules during the preclinical phase of drug discovery.

Two years of drug discovery experience and 13 years as academic investigator using zebrafish model in the fields of developmental neurobiology and cancer genetics at Centro de Biologia Molecular-Severo Ochoa (CSIC/Spain), National Institute of Medical Research (MRC/UK) and Department of Experimental and Health Sciences (UPF/Spain).